0001237899-12-000017.txt : 20120202 0001237899-12-000017.hdr.sgml : 20120202 20120202164357 ACCESSION NUMBER: 0001237899-12-000017 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120131 FILED AS OF DATE: 20120202 DATE AS OF CHANGE: 20120202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Terifay Robert J CENTRAL INDEX KEY: 0001391382 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 12566432 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 4 1 edgardoc.xml PRIMARY DOCUMENT X0304 4 2012-01-31 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001391382 Terifay Robert J 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 SVP Commercial Common Stock 2012-01-31 4 M 0 23128 21.92 A 32500 D Common Stock 2012-01-31 4 F 0 5628 90.07 D 26872 D Common Stock 2012-01-31 4 F 0 8061 90.07 D 18811 D Common Stock 2012-02-01 4 S 0 8539 90.54 D 10272 D Common Stock 2012-02-01 4 S 0 900 91.04 D 9372 D Common Stock 1387 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 21.92 2012-01-31 4 M 0 23128 D 2017-12-17 Common Stock 23128 12500 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 8,539 shares of Company stock on February 1, 2012 at prices ranging from $90.26 to $90.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2012 at each separate price. Represents volume-weighted average price of sales of 900 shares of Company stock on February 1, 2012 at prices ranging from $91.03 to $91.05. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2012 at each separate price. The stock option award vests in four equal annual installments, commencing one year after the date of grant. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case. /s/**Robert J. Terifay 2012-02-01